Paper Details

  1. Home
  2. Paper Details

A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.

Author: MonteroL

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study compared the efficacy and safety of azithromycin and cefaclor in treating skin and/or soft tissue infections in children. Both treatments were comparable in efficacy and well-tolerated, with a low incidence of side effects.
Paper Details　
Original Abstract of the Article :
An open, multicentre study was carried out in 200 paediatric patients between 6 months and 12 years of age with skin and/or soft tissue infections (mild-to-moderate dermatological conditions and abscesses) to compare the efficacy and safety of azithromycin and cefaclor oral suspensions. Patients wer...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/jac/37.suppl_c.125

データ提供：米国国立医学図書館（NLM）

Azithromycin and Cefaclor: A Tale of Two Antibiotics for Skin Infections

Skin infections, a common ailment that affects people of all ages, require prompt and effective treatment. This study investigates the efficacy and safety of two antibiotics, azithromycin and cefaclor, for treating skin and soft tissue infections in children. The researchers conducted a multicenter study to compare the effectiveness and tolerability of these two drugs in a group of 200 children. Their findings reveal a fascinating comparison, showcasing the strengths and limitations of each antibiotic.

Navigating the Desert of Skin Infections

The study found that both azithromycin and cefaclor were equally effective in treating skin and soft tissue infections in children. The researchers observed comparable cure rates and pathogen eradication rates with both antibiotics. This suggests that both drugs can serve as valuable weapons in the fight against these infections. However, the study also highlights the importance of considering the duration of treatment. Azithromycin, with its shorter treatment course, offered a more convenient option for patients and families, like a shortcut through a vast desert.

Antibiotic Choices: A Desert Oasis of Options

The study provides valuable insights into the effectiveness of azithromycin and cefaclor for treating skin and soft tissue infections in children. While both drugs are effective, azithromycin's shorter treatment course might be a preferable option for patients, especially in cases where convenience and adherence are important. This knowledge, like finding a cool oasis in the desert, can help physicians make informed decisions regarding antibiotic treatment.

Dr. Camel's Conclusion

This study demonstrates the efficacy and safety of both azithromycin and cefaclor for treating skin and soft tissue infections in children. The shorter treatment course of azithromycin makes it a viable option for patients and families seeking convenience. This study is a reminder that the world of antibiotics is vast and complex, and that informed choices are essential for optimizing patient care.
Date :
  1. Date Completed 1996-12-16
  2. Date Revised 2019-05-12
Further Info :

Pubmed ID

8818853

DOI: Digital Object Identifier

10.1093/jac/37.suppl_c.125

Related Literature

Article Analysis
・Side Effects of cefaclor
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.